Frequencies of circulating MAIT cells are diminished in chronic hCV, HIV and HCV/ HIV Co-Infection and do not recover during therapy

PLoS ONE

Volumn 11, Issue 7, 2016, Pages

  Spaan, Michelle ^a   Hullegie, Sebastiaan J ^a   Beudeker, Boris J B ^a   Kreefft, Kim ^a   Van Oord, Gertine W ^a   Groothuismink, Zwier M A ^a   Van Tilborg, Marjolein ^a   Rijnders, Bart ^a   De Knegt, Robert J ^a   Claassen, Mark A A ^a   Boonstra, Andre ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASUNAPREVIR; BOCEPREVIR; CD161 ANTIGEN; CD38 ANTIGEN; DACLATASVIR; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; PEGINTERFERON ALPHA2A; RIBAVIRIN; SOFOSBUVIR; TELAPREVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIVIRUS AGENT;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CELL STIMULATION; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EXPOSURE; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MUCOSAL ASSOCIATED INVARIANT T CELL; NATURAL KILLER CELL; OUTCOME ASSESSMENT; PHENOTYPE; T LYMPHOCYTE; TREATMENT DURATION; VIRUS LOAD; CASE CONTROL STUDY; COINFECTION; COMPLICATION; DRUG EFFECTS; HEPATITIS C, CHRONIC; HIV INFECTIONS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MUCOSAL-ASSOCIATED INVARIANT T CELL; PHYSIOLOGY; VIROLOGY;

ADULT; AGED; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; CASE-CONTROL STUDIES; COINFECTION; FLOW CYTOMETRY; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MUCOSAL-ASSOCIATED INVARIANT T CELLS;

EID: 84978422162     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0159243     Document Type: Article

References (34)

1. Randall RE, Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. Journal of General Virology. 2008; 89(Pt 1):1-47. PMID: 18089727.
2. Li Y, Li S, Duan X, Liu B, Yang C, Zeng P, et al. Activation of endogenous type I IFN signaling contributes to persistent HCV infection. Reviews in Medical Virology. 2014; 24(5):332-42. PMID: 24806972. doi: 10.1002/rmv.1795
3. Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005; 5(5):375-86. Epub 2005/05/03. doi: nri1604 [pii] doi: 10.1038/nri1604 PMID: 15864272.
4. Gerlach JT, Diepolder HM, Zachoval R, Gruener NH, Jung MC, Ulsenheimer A, et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology. 2003; 125(1):80-8. PMID: 12851873.
5. Hullegie SJ, Arends JE, Rijnders BJ, Irving WL, Salmon D, Prins M, et al. Current knowledge and future perspectives on acute hepatitis C infection. Clin Microbiol Infect. 2015. Epub 2015/04/22. doi: S1198-743X(15)00406-1 [pii] doi: 10.1016/j.cmi.2015.03.026 PMID: 25892133.
6. Spaan M, Boonstra A, Janssen HLA. Immunology of hepatitis C infection. Best Pract Res Clin Gastroenterol. 2012; 26(4):1049-61.
7. Cook KD, Whitmire JK. The depletion of NK cells prevents T cell exhaustion to efficiently control disseminating virus infection. Journal of Immunology. 2013; 190(2):641-9. PMID: 23241878.
8. Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, Liew FY, et al. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. Journal of Immunology. 2002; 169(8):4279-87. PMID: 12370359.
9. Bosinger SE, Utay NS. Type I interferon: understanding its role in HIV pathogenesis and therapy. Current HIV/AIDS Reports. 2015; 12(1):41-53. PMID: 25662992. doi: 10.1007/s11904-014-0244-6
10. Le Bourhis L, Martin E, Peguillet I, Guihot A, Froux N, Core M, et al. Antimicrobial activity of mucosalassociated invariant T cells. Nat Immunol. 2010; 11(8):701-8. Epub 2010/06/29. doi: ni.1890 [pii] doi: 10.1038/ni.1890 PMID: 20581831.
11. Gapin L. Check MAIT. Journal of Immunology. 2014; 192(10):4475-80. PMID: 24795465.
12. Ussher JE, Bilton M, Attwod E, Shadwell J, Richardson R, de Lara C, et al. CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner. European Journal of Immunology. 2014; 44(1):195-203. PMID: 24019201. doi: 10.1002/eji.201343509
13. Chua WJ, Hansen TH. Bacteria, mucosal-associated invariant T cells and MR1. Immunol Cell Biol. 2010; 88(8):767-9. PMID: 20733595. doi: 10.1038/icb.2010.104
14. Le Bourhis L, Guerri L, Dusseaux M, Martin E, Soudais C, Lantz O. Mucosal-associated invariant T cells: unconventional development and function. Trends in Immunology. 2011; 32(5):212-8. PMID: 21459674. doi: 10.1016/j.it.2011.02.005
15. Leeansyah E, Ganesh A, Quigley MF, Sonnerborg A, Andersson J, Hunt PW, et al. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood. 2013; 121(7):1124-35. PMID: 23243281. doi: 10.1182/blood-2012-07-445429
16. Eberhard JM, Hartjen P, Kummer S, Schmidt RE, Bockhorn M, Lehmann C, et al. CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression. PLoS One. 2014; 9(11):e111323. Epub 2014/11/05. doi: 10.1371/journal.pone. 0111323 PONE-D-14-22005 [pii]. PMID: 25369333; PubMed Central PMCID: PMC4219715.
17. Cosgrove C, Ussher JE, Rauch A, Gartner K, Kurioka A, Huhn MH, et al. Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. Blood. 2013; 121(6):951-61. Epub 2012/12/21. doi: blood-2012-06-436436 [pii] doi: 10.1182/blood-2012-06-436436 PMID: 23255555; PubMed Central PMCID: PMC3567342.
18. Wong EB, Akilimali NA, Govender P, Sullivan ZA, Cosgrove C, Pillay M, et al. Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection. PLoS One. 2013; 8(12):e83474. Epub 2014/01/07. doi: 10.1371/journal.pone.0083474 PONE-D-13-28479 [pii]. PMID: 24391773; PubMed Central PMCID: PMC3877057.
19. Ussher JE, Phalora P, Cosgrove C, Hannaway RF, Rauch A, Gunthard HF, et al. Molecular Analyses Define Valpha7.2-Jalpha33+ MAIT Cell Depletion in HIV Infection: A Case-Control Study. Medicine (Baltimore). 2015; 94(29):e1134. Epub 2015/07/23. doi: 10.1097/MD.0000000000001134 00005792-201507040-00006 [pii]. PMID: 26200614; PubMed Central PMCID: PMC4603017.
20. Saeidi A, Tien Tien VL, Al-Batran R, Al-Darraji HA, Tan HY, Yong YK, et al. Attrition of TCR Valpha7.2+ CD161++ MAIT cells in HIV-tuberculosis co-infection is associated with elevated levels of PD-1 expression. PLoS One. 2015; 10(4):e0124659. Epub 2015/04/22. doi: 10.1371/journal.pone.0124659 PONE-D-15-00668 [pii]. PMID: 25894562; PubMed Central PMCID: PMC4403924.
21. Leeansyah E, Svard J, Dias J, Buggert M, Nystrom J, Quigley MF, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. //. 2015; 11(8):e1005072. Epub 2015/08/22. doi: 10.1371/journal.ppat.1005072 PPATHOGENS-D-15-00475 [pii]. PMID: 26295709; PubMed Central PMCID: PMC4546682.
22. Fernandez CS, Amarasena T, Kelleher AD, Rossjohn J, McCluskey J, Godfrey DI, et al. MAIT cells are depleted early but retain functional cytokine expression in HIV infection. Immunol Cell Biol. 2015; 93 (2):177-88. Epub 2014/10/29. doi: icb201491 [pii] doi: 10.1038/icb.2014.91 PMID: 25348935.
23. Hengst J, Strunz B, Deterding K, Ljunggren HG, Leeansyah E, Manns MP, et al. Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy. European Journal of Immunology. 2016. Epub 2016/06/15. doi: 10.1002/eji.201646447 PMID: 27296288.
24. Claassen MAA, de Knegt RJ, Turgut D, Groothuismink ZMA, Janssen HLA, Boonstra A. Negative regulation of hepatitis C virus specific immunity is highly heterogeneous and modulated by pegylated interferon-alpha/ribavirin therapy. PLoS One. 2012; 7(11):e49389. Epub 2012/11/13. doi: ARTN e49389 doi: 10.1371/journal.pone.0049389 ISI:000312269500107; PubMed Central PMCID: PMC3493527. PMID: 23145169
25. European Association for Study of L. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol. 2014; 60(2):392-420. Epub 2013/12/18. doi: S0168-8278(13)00794-0 [pii] doi: 10.1016/j.jhep.2013.11.003 PMID: 24331294.
26. Spaan M, van Oord G, Kreefft K, Hou J, Hansen BE, Janssen HL, et al. Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment. J Infect Dis. 2015. Epub 2015/08/01. doi: jiv391 [pii] doi: 10.1093/infdis/jiv391 PMID: 26223768.
27. Golden-Mason L, Rosen HR. Natural killer cells: multifaceted players with key roles in hepatitis C immunity. Immunological Reviews. 2013; 255(1):68-81. PMID: 23947348. doi: 10.1111/imr.12090
28. Hotho DM, Kreefft K, Groothuismink ZM, Janssen HL, de Knegt RJ, Boonstra A. Natural killer cell activity and function in chronic HCV-infected patients during peg interferon and ribavirin: early effects of active substance use. Antiviral Res. 2013; 97(3):347-55. Epub 2013/01/08. doi: S0166-3542(12) 00316-6 [pii] doi: 10.1016/j.antiviral.2012.12.025 PMID: 23291200.
29. Lunemann S, Schlaphoff V, Cornberg M, Wedemeyer H. NK cells in hepatitis C: role in disease susceptibility and therapy. Digestive Diseases. 2012; 30 Suppl 1:48-54. PMID: 23075868. doi: 10.1159/ 000341680
30. Gonzalez VD, Landay AL, Sandberg JK. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection. Clin Immunol. 2010; 135(1):12-25. Epub 2010/01/27. doi: S1521-6616(09)00913-9 [pii] doi: 10.1016/j.clim.2009.12.005 PMID: 20100670.
31. Barathan M, Mohamed R, Vadivelu J, Chang LY, Saeidi A, Yong YK, et al. Peripheral loss of CD8(+) CD161(++) TCRValpha7.2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients. Eur J Clin Invest. 2016; 46(2):170-80. Epub 2015/12/19. doi: 10.1111/eci.12581 PMID: 26681320.
32. Vinton C, Wu F, Rossjohn J, Matsuda K, McCluskey J, Hirsch V, et al. Mucosa-Associated Invariant T Cells Are Systemically Depleted in Simian Immunodeficiency Virus-Infected Rhesus Macaques. J Virol. 2016; 90(9):4520-9. Epub 2016/02/26. doi: JVI.02876-15 [pii] doi: 10.1128/JVI.02876-15 PMID: 26912615.
33. Iannello A, Debbeche O, Samarani S, Ahmad A. Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS. J Leukoc Biol. 2008; 84 (1):1-26. Epub 2008/04/05. doi: jlb.0907650 [pii] doi: 10.1189/jlb.0907650 PMID: 18388298.
34. Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, Heitman J, et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol. 2009; 83(8):3719-33. Epub 2009/01/30. doi: JVI.01844-08 [pii] doi: 10.1128/JVI.01844-08 PMID: 19176632; PubMed Central PMCID: PMC2663284.